ACE and obesity due to melanocortin 4 receptor deficiency: Furthermore, a subanalysis of the ACCOMPLISH trial found that patients with obesity taking a combination of ACE inhibitors and diuretics were 39%, 60%, and 40% less likely to experience primary CVD morbidity outcomes, CVD deaths, and total stroke, respectively, when compared to normal weight individuals taking the same medications.